Sesamin reduces acute hepatic injury induced by lead coupled with lipopolysaccharide

Journal of the Chinese Medical Association

Volumn 77, Issue 5, 2014, Pages 227-233

  Chiang, Hsiu Mei ^a   Chang, Hsiang ^b   Yao, Pei Wun ^c   Chen, Yuh Shuen ^d   Jeng, Kee Ching ^e   Wang, Jen Shu ^f   Hou, Chien Wei ^b  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b YUANPEI UNIVERSITY   (Taiwan)

^c NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^d HUNGKUANG UNIVERSITY   (Taiwan)

^e TUNGS' TAICHUNG METROHARBOR HOSPITAL   (Taiwan)

^f Buddhist Tzu Chi General   (Taiwan)

Author keywords

Cyclooxygenase 2; Inducible nitric oxide synthase; Kinases; Mitogen activated protein; Sesamin

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; CYCLOOXYGENASE 2; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45 BETA; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; INTERLEUKIN 6; LEAD ACETATE; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE; PROTEIN C FOS; REACTIVE OXYGEN METABOLITE; SESAMIN; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; 1,3 DIOXOLANE DERIVATIVE; LIGNAN; ORGANOMETALLIC COMPOUND;

ACUTE HEPATIC INJURY; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; ENZYME BLOOD LEVEL; LIVER; LIVER INJURY; MALE; NONHUMAN; PROTEIN BLOOD LEVEL; RAT; ACUTE DISEASE; ANIMAL; DRUG-INDUCED LIVER INJURY; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ACUTE DISEASE; ANIMALS; DIOXOLES; DRUG-INDUCED LIVER INJURY; LIGNANS; LIPOPOLYSACCHARIDES; MALE; ORGANOMETALLIC COMPOUNDS; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84899622061     PISSN: 17264901     EISSN: 17287731     Source Type: Journal    
DOI: 10.1016/j.jcma.2014.02.010     Document Type: Article

References (35)

1. Ercal N., Gurer-Orhan H., Aykin-Burns N. Toxic metals and oxidative stress: Part 1. Mechanisms involved in metal-induced oxidative damage. Curr Top Med Chem 2001, 1:529-539.
2. Rousseau M.C., Straif K., Siemiatycki J. IARC carcinogen update. Environ Health Perspect 2005, 113:A580-A581.
3. Patrick L. Lead toxicity, a review of the literature: Part 1. Exposure, evaluation, and treatment. Altern Med Rev 2006, 11:2-22.
4. Goyer R.A., Clarkson T.W. 2001 Toxic effects of metals. Toxicology: the basic science of poisons 1994, 827-834. McGraw-Hill, New York. 6th ed. C.D. Klaassen (Ed.).
5. Needleman H. Lead poisoning. Annu Rev Med 2004, 55:209-222.
6. Dentener M.A., Greve J.W., Maessen J.G., Buurman W.A. Role of tumour necrosis factor in the enhanced sensitivity of mice to endotoxin after exposure to lead. Immunopharmacol Immunotoxicol 1989, 11:321-334.
7. Honchel R., Marsano L., Cohen D., Shedlofsky S., McClain C.J. Lead enhances lipopolysaccharide and tumor necrosis factor liver injury. J Lab Clin Med 1991, 117:202-208.
8. Liu M.Y., Cheng Y.J., Chen C.K., Yang B.C. Co-exposure of lead and lipopolysaccharide-induced liver injury in rats: involvement of nitric oxide-initiated oxidative stress and TNF-α. Shock 2005, 23:360-364.
9. Milosevic N., Maier P. Lead stimulates intercellular signaling between hepatocytes and Kupffer cells. Eur J Pharmacol 2000, 401:317-328.
10. Leist M., Gantner F., Jilg S., Wendel A. Activation of the 55 kDa TNF receptor is necessary and sufficient for TNF-induced liver failure, hepatocyte apoptosis, and nitrite release. J Immunol 1995, 154:1307-1316.
11. Ulrich T.R., Watson L.R., Yin S.M., Gou K.Z., Wang P., Thang H., et al. The intratracheal administration of endotoxin and cytokines: I. Characterization of LPS-induced IL-1 and TNF mRNA expression and the LPS-, IL-1-, and TNF-induced inflammatory infiltrate. Am J Pathol 1991, 138:1485-1496.
12. Scherle P.A., Jones E.A., Favata M.F., Daulerio A.J., Covington M.B., Nurnberg S.A., et al. Inhibition of MAP kinase kinase prevents cytokine and prostaglandin E2 production in lipopolysaccharide-stimulated monocytes. J Immunol 1998, 161:5681-5686.
13. Comalada M., Xaus J., Valledor A.F., Lopez-Lopez C. Pennington, DJ, Celada A. PKC epsilon is involved in JNK activation that mediates LPS-induced TNF-α, which induces apoptosis in macrophages. Am J Physiol Cell Physiol 2003, 285:C1235-C1245.
14. Cheng Y.J., Liu M.Y. Modulation of tumor necrosis factor-α and oxidative stress through protein kinase C and p42/44 mitogen-activated protein kinase in lead increases lipopolysaccharide-induced liver damage in rats. Shock 2005, 24:188-193.
15. Jeng K.C., Hou R.C., Wang J.C., Ping L.I. Sesamin inhibits lipopolysaccharide-induced cytokine production by suppression of p38 mitogen-activated protein kinase and nuclear factor-kappaB. Immunol Lett 2005, 97:101-106.
16. Hou R.C., Chen H.L., Tzen J.T., Jeng K.C. Effect of sesame antioxidants on LPS-induced NO production by BV2 microglial cells. Neuroreport 2003, 14:1815-1819.
17. Koistinaho M., Koistinaho J. Role of p38 and p44/42 mitogen-activated protein kinases in microglia. Glia 2002, 40:175-183.
18. Koistinaho M., Kettunen M.I., Goldsteins G., Keinänen R., Salminen A., Ort M., et al. Beta-amyloid precursor protein transgenic mice that harbor diffuse A beta deposits but do not form plaques show increased ischemic vulnerability: role of inflammation. Proc Natl Acad Sci U S A 2002, 99:1610-1615.
19. Hsu D.Z., Su S.B., Chien S.P., Chiang P.J., Li Y.H., Lo Y.J., et al. Effect of sesame oil on oxidative-stress-associated renal injury in endotoxemic rats: involvement of nitric oxide and proinflammatory cytokines. Shock 2005, 24:276-280.
20. Hsu C.C., Hsu C.L., Tsai S.E., Fu T.Y., Yen G.C. Protective effect of Millettia reticulata Benth against CCl(4)-induced hepatic damage and inflammatory action in rats. J Med Food 2009, 12:821-828.
21. Deng J.S., Chang Y.C., Wen C.L., Liao J.C., Hou W.C., Amagaya S., et al. Hepatoprotective effect of the ethanol extract of Vitis thunbergii on carbon tetrachloride-induced acute hepatotoxicity in rats through anti-oxidative activities. J Ethnopharmacol 2012, 142:795-803.
22. Xu H., Guo T., Guo Y.F., Je Zhang, Li Y., Feng W., et al. Characterization and protection on acute liver injury of a polysaccharide MP-I from Mytilus coruscus. Glycobiology 2008, 18:97-103.
23. Mei M.H., An W., Zhang B.H., Shao Q., Gong D.Z. Hepatic stimulator substance protects against acute liver failure induced by carbon tetrachloride poisoning in mice. Hepatology 1993, 17:638-644.
24. Jaeschke H. Reactive oxygen and mechanisms of inflammatory liver injury: present concepts. J Gastroenterol Hepatol 2011, 1:173-179.
25. Riordan S.M., Williams R. Mechanisms of hepatocyte injury, multiorgan failure, and prognostic criteria in acute liver failure. Semin Liver Dis 2003, 23:203-215.
26. Holper K., Trejo R.A., Brettschneider L., Di Luzio N.R. Enhancement of endotoxin shock in the lead-sensitized subhuman primate. Surg Gynecol Obstet 1973, 136:593-601.
27. Trejo R.A., Di Luzio N.R., Loose L.D., Hoffman E. Reticuloendothelial and hepatic functional alterations following lead acetate administration. Exp Mol Pathol 1972, 17:145-158.
28. Heyninck K., Wullaert A., Beyaert R. Nuclear factor-kappa B plays a central role in tumour necrosis factor-mediated liver disease. Biochem Pharmacol 2003, 66:1409-1415.
29. González-Amaro R., Garcia-Monzón C., Garcia-Buey L., Moreno-Otero R., Alonso J.L., Yague E., et al. Induction of tumor necrosis factor alpha production by human hepatocytes in chronic viral hepatitis. J Exp Med 1994, 179:841-848.
30. Muto Y., Nouri-Aria K.T., Meager A., Alexander G.J., Eddleston A.L., Williams R. Enhanced tumour necrosis factor and interleukin-1 in fulminant hepatic failure. Lancet 1988, 2:72-74.
31. Bird G.L., Sheron N., Goka A.K., Alexander G.J., Williams R.S. Increased plasma tumor necrosis factor in severe alcoholic hepatitis. Ann Intern Med 1990, 112:917-920.
32. Izuta S., Ueki M., Ueno M., Nishina K., Shiozawa S., Maekawa N. T-5224, a selective inhibitor of c-Fos/activator protein-1, attenuates lipopolysaccharide- induced liver injury in mice. Biotechnol Lett 2012, 34:2175-2182.
33. Hou R.C., Huang H.M., Tzen J.T., Jeng K.C. Protective effects of sesamin and sesamolin on hypoxic neuronal and PC12 cells. J Neurosci Res 2003, 74:123-133.
34. Zhang N., Ahsan M.H., Zhu L., Sambucetti L.C., Purchio A.F., West D.B. NF-kappaB and not the MAPK signaling pathway regulates GADD45beta expression during acute inflammation. J Biol Chem 2005, 280:21400-21408.
35. Tamaki N., Hatano E., Taura K., Tada M., Kodama Y., Nitta T., et al. CHOP deficiency attenuates cholestasis-induced liver fibrosis by reduction of hepatocyte injury. Am J Physiol Gastrointest Liver Physiol 2008, 294:G498-G505.